You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 6,005,001


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,005,001
Title: Pharmaceutical composition
Abstract:Non-greasy topical solutions, emulsion gels or lotions comprising as the active agent a compound of formula I ##STR1## and a lower alkanol, and if desired together with a solubilizing agent or an oil phase such as isopropyl myristate are useful delivery systems.
Inventor(s): Richter; Friedrich (Schonbuhl, CH), Steiger; Michel (Bern, CH)
Assignee: Novartis AG (formerly Sandoz AG) (Basel, CH)
Application Number:09/181,651
Patent Claim Types:
see list of patent claims
Composition; Compound; Use; Process;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of U.S. Patents: A Detailed Analysis

Introduction to U.S. Patent Law

Patents in the United States are governed by the Patent Act (35 U.S. Code), which established the United States Patent and Trademark Office (USPTO). This framework sets the standards for what can be patented, the process of patent application, and the rights conferred by a patent[1][4].

Patentability Requirements

For an invention to be patentable, it must meet several key criteria:

  • Usefulness: The invention must be operable and provide some tangible benefit.
  • Novelty: The invention must not be fully anticipated by prior patents, publications, or other state of the art knowledge.
  • Nonobviousness: The invention must not have been readily within the ordinary skills of a competent artisan at the time it was made.
  • Patentable Subject Matter: The invention must fall within a category of subject matter that is eligible for patent protection[4].

The Role of Patent Claims

Patent claims are the heart of a patent application, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and supported by the description of the invention. There are two main types of claims:

  • Independent Claims: These stand alone and define the invention without reference to other claims.
  • Dependent Claims: These refer back to and further limit an independent claim[1][3].

Measuring Patent Scope

Patent scope is a critical aspect of patent quality and is often debated in terms of breadth and clarity. Two simple metrics used to measure patent scope are:

  • Independent Claim Length: Longer claims often indicate broader scope.
  • Independent Claim Count: A higher number of independent claims can suggest a wider scope of protection[3].

The Patent Examination Process

During the examination process, the USPTO evaluates the patent application to ensure it meets the patentability requirements. This process can significantly narrow the scope of patent claims. Research has shown that narrower claims at publication are associated with a higher probability of grant and a shorter examination process. The examination process tends to reduce the scope of patent claims in terms of both claim length and claim count, with more significant changes occurring over longer examination durations[3].

Economic Impact and Value of Patents

Patents confer exclusive rights to their owners, allowing them to exclude others from making, using, offering for sale, or selling the covered invention. This exclusivity can have significant economic implications, including increased licensing and litigation costs. The value of a patent can vary widely, with median asking prices ranging from $108,000 to $250,000 per document or family, respectively. Notable transactions include the $4.5 billion paid by Rockstar Bidco for 6,000 patent documents from Nortel, highlighting the substantial economic value that patents can hold[5].

Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents granted between 1976 and 2014 and patent applications published between 2001 and 2014. This dataset includes parsed claims text, claim-level statistics, and document-level statistics, offering insights into patent scope and claim structure. It is a valuable resource for analyzing trends and metrics related to patent claims[2].

Case Study: United States Patent 6,005,001

To illustrate the concepts discussed, let's consider a hypothetical analysis of United States Patent 6,005,001, though the specific details of this patent are not provided here.

Patent Claims Analysis

  • Independent Claims: Analyze the length and count of independent claims to understand the breadth of protection sought.
  • Dependent Claims: Examine how dependent claims further limit the independent claims, providing a more detailed scope of the invention.
  • Claim Language: Evaluate the clarity and specificity of the claim language to assess the patent's overall scope and potential for litigation.

Patent Scope Metrics

  • Independent Claim Length and Count: Apply the metrics discussed to measure the patent scope. Longer independent claims and a higher count of independent claims may indicate a broader scope.
  • Examination Process Impact: Review the history of the patent application to see how the examination process may have narrowed the claims, affecting the final scope of the patent.

Economic and Legal Implications

  • Exclusive Rights: Understand the exclusive rights granted by the patent and how these rights can be enforced.
  • Licensing and Litigation: Consider the potential economic impact of the patent, including licensing fees and litigation costs.

Key Takeaways

  • Patent Claims: Are crucial in defining the scope of an invention and must be clear, concise, and supported by the description.
  • Patent Scope: Can be measured using metrics such as independent claim length and count, and is often narrowed during the examination process.
  • Economic Value: Patents can have significant economic value, with prices varying widely based on the invention's novelty, nonobviousness, and utility.
  • Examination Process: Plays a critical role in ensuring that patents meet the patentability requirements and in shaping the final scope of the patent.

FAQs

What are the basic requirements for an invention to be patentable in the United States?

An invention must be useful, novel, nonobvious, and fall within a category of patentable subject matter.

How are patent claims structured?

Patent claims include independent claims that stand alone and define the invention, and dependent claims that refer back to and further limit an independent claim.

What metrics are used to measure patent scope?

Common metrics include independent claim length and independent claim count.

How does the patent examination process affect patent claims?

The examination process tends to narrow the scope of patent claims, with more significant changes occurring over longer examination durations.

What is the economic value of patents?

The economic value of patents can vary widely, with median asking prices ranging from $108,000 to $250,000 per document or family, and significant transactions such as the $4.5 billion paid for Nortel's patent portfolio.

Sources

  1. BitLaw: Patent Law in the United States.
  2. USPTO: Patent Claims Research Dataset.
  3. SSRN: Patent Claims and Patent Scope.
  4. CRS Reports: Patents and Innovation Policy.
  5. Perpetual Motion Patents: The Value of a Patent.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,005,001

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,005,001

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9110884May 20, 1991
United Kingdom9111477May 29, 1991

International Family Members for US Patent 6,005,001

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 400517 ⤷  Subscribe
Austria A102392 ⤷  Subscribe
Australia 1631792 ⤷  Subscribe
Australia 647922 ⤷  Subscribe
Brazil 1100213 ⤷  Subscribe
Canada 2068957 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.